|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||
| Depreciation | |||||
| Net accretion on loans | |||||
| Amortization of subordinated notes issuance costs | |||||
| Amortization of junior subordinated debentures | |||||
| Net (accretion) amortization on securities | |||||
| Amortization of intangible assets | |||||
| Software amortization | |||||
| Deferred taxes, net | |||||
| Credit loss expense (benefit) | |||||
| Stock based compensation | |||||
| Net (gains) losses on sale or call of debt securities | |||||
| Net (gains) losses on equity securities | |||||
| Net OREO (gains) losses and valuation adjustments | |||||
| Origination of loans held for sale | |||||
| Purchases of loans held for sale | |||||
| Proceeds from sale of loans originated or purchased for sale | |||||
| Net (gains) losses on sale of loans | |||||
| Net change in operating leases | |||||
| Change in estimated fair value of indemnification asset | |||||
| Change in estimated fair value of revenue share asset | |||||
| (Increase) decrease in other assets | |||||
| Increase (decrease) in other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of securities available for sale | |||||
| Proceeds from sales of securities available for sale | |||||
| Proceeds from maturities, calls, and pay downs of securities available for sale | |||||
| Proceeds from maturities, calls, and pay downs of securities held to maturity | |||||
| Proceeds from sales of equity securities | |||||
| Purchases of loans held for investment | |||||
| Proceeds from sale of loans | |||||
| Net change in loans | |||||
| Purchases of premises and equipment | |||||
| Expenditures for capitalized software | |||||
| Net proceeds from sale of OREO | |||||
| (Purchases) redemptions of FHLB and other restricted stock, net | |||||
| Proceeds from BOLI | |||||
| Purchase of Bank Owned Life Insurance | |||||
| Acquired intangible assets | |||||
| Net cash paid for acquisitions | |||||
| Proceeds from sale of disposal group | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase (decrease) in deposits | |||||
| Increase (decrease) in customer repurchase agreements | |||||
| Increase (decrease) in Federal Home Loan Bank advances | |||||
| Proceeds from other borrowings, net | |||||
| Repayment of other borrowings | |||||
| Preferred stock dividends | |||||
| Stock option exercises, net | |||||
| Proceeds from employee stock purchase plan common stock issuance | |||||
| Purchase of treasury stock, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
| Cash paid for operating lease liabilities | |||||
| Supplemental noncash disclosures: | |||||
| Loans transferred to OREO | |||||
| Loans held for investment transferred to loans held for sale | |||||
| Assets transferred to assets held for sale | |||||
| Deposits transferred to deposits held for sale | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Securities available for sale purchased, not settled | |||||
| Indemnification reduction | |||||
| Indemnification Asset | |||||
| Non-cash consideration received from sale of loan portfolio or disposal group | |||||
| Stock issued as consideration paid for acquisitions | |||||
Loading...
